Munir, T
Howard, D R
McParland, L
Pocock, C
Rawstron, A C
Hockaday, A
Varghese, A
Hamblin, M
Bloor, A
Pettitt, A
Fegan, C https://orcid.org/0000-0001-9685-0621
Blundell, J
Gribben, J G
Phillips, D
Hillmen, P
Article History
Received: 30 September 2016
Revised: 24 November 2016
Accepted: 29 November 2016
First Online: 20 April 2017
Competing interests
: Professor Hillmen received research funding and speakers’ fees from Roche Products Limited. Dr Rawstron, Dr Munir, Dr Fegan and Dr Hamblin reports personal fees from Roche Products Limited. Dr Bloor has also reported personal, consultancy/advisory and speaker’s fees from Roche Products Limited. Professor Gribben reports personal fees and expenses from Roche Products Limited. The other authors declare no conflict of interest.